BX Swiss TOP 30 CHF
1.386,27
PKT
+7,48
PKT
+0,54
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.01.13 | Swisscom halten | Nomura | |
| 30.01.13 | UBS halten | BNP PARIBAS | |
| 30.01.13 | Holcim kaufen | UBS AG | |
| 30.01.13 | Holcim kaufen | UBS AG | |
| 30.01.13 | Roche kaufen | Cheuvreux SA | |
| 30.01.13 | Novartis kaufen | UBS AG | |
| 29.01.13 | Novartis kaufen | Jefferies & Company Inc. | |
| 29.01.13 | Nestlé kaufen | Jefferies & Company Inc. | |
| 29.01.13 | UBS halten | UBS AG | |
| 28.01.13 | Novartis halten | Goldman Sachs Group Inc. | |
| 28.01.13 | Roche kaufen | Goldman Sachs Group Inc. | |
| 28.01.13 | Roche kaufen | S&P Equity Research | |
| 28.01.13 | UBS kaufen | Credit Suisse Group | |
| 28.01.13 | Swiss Re halten | Exane-BNP Paribas SA | |
| 28.01.13 | Zurich Insurance halten | Exane-BNP Paribas SA | |
| 25.01.13 | UBS Current Investment List | Goldman Sachs Group Inc. | |
| 25.01.13 | Richemont | HSBC | |
| 25.01.13 | Partners Group halten | Vontobel Research | |
| 25.01.13 | UBS kaufen | Vontobel Research | |
| 25.01.13 | Lonza halten | Vontobel Research | |
| 25.01.13 | Zurich Insurance halten | Vontobel Research | |
| 25.01.13 | Kühne + Nagel International kaufen | boerse.de-Aktienbrief | |
| 24.01.13 | Novartis Kaufen | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 24.01.13 | Novartis Halten | Credit Suisse Group | |
| 24.01.13 | Logitech halten | Vontobel Research | |
| 24.01.13 | Novartis | Citigroup Corp. | |
| 24.01.13 | Lonza halten | Vontobel Research | |
| 24.01.13 | Novartis | Exane-BNP Paribas SA | |
| 23.01.13 | Logitech halten | Vontobel Research | |
| 22.01.13 | Novartis | Exane-BNP Paribas SA | |
| 22.01.13 | Kühne + Nagel International Halten | Credit Suisse Group | |
| 22.01.13 | Richemont Strong Buy | UBS AG | |
| 22.01.13 | Nestlé | Citigroup Corp. | |
| 22.01.13 | UBS | Citigroup Corp. | |
| 22.01.13 | UBS | Citigroup Corp. | |
| 22.01.13 | Kühne + Nagel International halten | Vontobel Research | |
| 22.01.13 | Kühne + Nagel International halten | Vontobel Research | |
| 22.01.13 | Roche | Exane-BNP Paribas SA | |
| 21.01.13 | Swiss Re Current Investment List | Goldman Sachs Group Inc. | |
| 21.01.13 | Swiss Life Current Investment List | Goldman Sachs Group Inc. |